Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Targeted Anticancer Therapies Congress 2021, 1-2 March

23 Feb 2021

Lugano, Switzerland, 23 February 2021 - The ESMO Targeted Anticancer Therapies Congress 2021, designed for basic scientists, physicians and translational researchers belonging to academic settings, industry and regulatory agencies will be held as a virtual meeting.

The scientific programme will provide new data and insightful presentations in the area of drug discovery and development for a broad range of targets, precision medicine and early clinical trial methodology. World renowned experts will discuss breakthroughs in the microbiome, oncolytic viruses and how to incorporate genomics into early drug development.

Programme highlights

  • Immune based therapies including ADCs, cytokines, multitargeted agents and cell-based therapies
  • Oncolytic viruses
  • The microbiome as a tool and a target
  • Pre-clinical testing to identify effective combination strategies
  • Incorporating genomics into early drug development
  • Practical aspects of optimising molecular tumour boards for phase I trials

TAT2021 Honorary Award

Prof. Ruth Plummer will be presented with the TAT 2021 Honorary Award for taking many new cancer drugs into the clinic that have become standard treatments with proven patient benefit. She will deliver a keynote lecture entitled “Academic drug discovery – Is partnership with industry a marriage made in heaven?” (Monday 1 March, from 11:40 to 12:45).

During the same session Dr. Lillian Siu, recipient of the TAT 2020 Honorary Award for her pivotal contributions in the development of new anticancer drugs, will also deliver her keynote lecture entitled “Rear view mirror and crystal ball of oncology drug development”.

Media registration

ESMO welcomes media interested in reporting from the ESMO events and on cancer issues. Only through the official accreditation process with the ESMO Media Registration Form, accredited media representatives will be able to access scientific and educational sessions (live streamed and on-demand), live chat and Q&A, e-posters, virtual exhibition and industry satellite symposia, Congress webcasts. 

Further information

ESMO Press Office
media@esmo.org

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings